Radiotherapy and Survival in Prostate Cancer Patients: A Population-Based Study

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 15-23

  Zhou, Esther H ^a   Ellis, Rodney J ^a,d   Cherullo, Edward ^a   Colussi, Valdir ^a   Xu, Fang ^a   Chen, Wei Dong ^a,b,c   Gupta, Sanjay ^a   Whalen, Christopher C ^a   Bodner, Donald ^a   Resnick, Martin I ^a   Rimm, Alfred A ^a   Koroukian, Siran M ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Northeast Ohio Medical University   (United States)

Author keywords

Population based study; Prostate cancer; Survival; Treatment modalities

Indexed keywords

ADMINISTRATIVE DATA PROCESSING; FINANCIAL DATA PROCESSING; PINCH EFFECT; RADIOTHERAPY; REGRESSION ANALYSIS; WINDOWS OPERATING SYSTEM;

ANDROGEN DEPRIVATION THERAPIES; BRACHYTHERAPY; COMBINATION THERAPIES; CONFIDENCE INTERVALS; CONSERVATIVE MANAGEMENTS; DEFINITIVE THERAPIES; DISTANT DISEASES; EXTERNAL BEAM RADIOTHERAPIES; GLEASON SCORES; HAZARD RATIOS; MONO THERAPIES; MULTIPLE REGRESSION MODELS; POPULATION-BASED STUDY; PROSTATE CANCER; PROSTATE CANCERS; RADICAL PROSTATECTOMIES; SURVEILLANCE SYSTEMS; SURVIVAL; SURVIVAL RATES; TREATMENT MODALITIES;

POPULATION STATISTICS;

AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; CONFIDENCE INTERVAL; DEATH CERTIFICATE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; GLEASON SCORE; HUMAN; LOCAL METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; HUMANS; MALE; OHIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 57649083064     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.001     Document Type: Article

References (35)

1. American Cancer Society. Cancer facts and figures, 2007 (2007), ACS, Atlanta, GA
2. Thompson I., Thrasher J.B., Aus G., et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177 (2007) 2106-2131
3. Wilt T.J., Macdonald R., Rutks I., et al. Systematic review: The comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148 (2008) 435-448
4. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
5. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
6. Ciezki J.P., Klein E.A., Angermeier K., et al. A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiation therapy, or radical prostatectomy. Int J Radiat Oncol Biol Phys 60 (2004) 1347-1350
7. Roemeling S., Roobol M.J., Postma R., et al. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 50 (2006) 475-482
8. Bracarda S., de Cobelli O., Greco C., et al. Cancer of the prostate. Crit Rev Oncol Hematol 56 (2005) 379-396
9. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early CaP. N Engl J Med 352 (2005) 1977-1984
10. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002) 790-796
11. Zeliadt S.B., Potosky A.L., Etzioni R., et al. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology 64 (2004) 1171-1176
12. Denberg T.D., Beaty B.L., Kim F.J., et al. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103 (2005) 1819-1825
13. Wong Y.N., Mitra N., Hudes G., et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296 (2006) 2683-2693
14. Lu-Yao G., Moore D.F., Oleynick J.U., et al. Population based study of hormonal therapy and survival in men with metastatic prostate cancer. J Urol 177 (2007) 535-539
15. Sylvester J.E., Blasko J.C., Grimm P.D., et al. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: The Seattle experience. Int J Radiat Oncol Biol Phys 57 (2003) 944-952
16. Potters L., Morgenstern C., Calugaru E., et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 173 (2005) 1562-1566
17. Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
18. International classification of disease, 9th revision, clinical modification (1994), McGraw Hill, New York
19. Charlson M.E., Sax F.L., MacKenzie C.R., et al. Morbidity during hospitalization: Can we predict it?. J Chronic Dis 40 (1987) 705-712
20. Holmberg L., Bill-Axelson A., Helgesen F., et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347 (2002) 781-789
21. Alibhai S.M., and Klotz L.H. A systematic review of randomized trials in localized prostate cancer. Can J Urol 11 (2004) 2110-2117
22. Albertsen P.C., Hanley J.A., and Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095-2101
23. Kulkarni G.S., Lockwood G., Evans A., et al. Clinical predictors of Gleason score upgrading implications for patients considering watchful waiting, active surveillance, or brachytherapy. Cancer 109 (2007) 2432-2438
24. Klotz L. Active surveillance for favorable risk prostate cancer: What are the results, and how safe is it?. Semin Radiat Oncol 18 (2008) 2-6
25. Dall'era M.A., Cooperberg M.R., Chan J.M., et al. Active surveillance for early-stage prostate cancer: Review of the current literature. Cancer 112 (2008) 1650-1659
26. Nilsson S., Norlén B.J., and Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 43 (2004) 316-381
27. Ellis R.J., Zhou E.H., Fu P., et al. Single photon emission computerized tomography and computerized tomography image set co-registration plus capromab pendetide independently predicts biochemical failure. J Urol 179 (2008) 1768-1773 discussion 1773-1774
28. Stock R.G., Ho A., Cesaretti J.A., et al. Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control. Int J Radiat Oncol Biol Phys 66 (2006) 389-394
29. Carter H.B., Ferrucci L., Kettermann A., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521-1527
30. Merrick G.S., Butler W.M., Galbreath R.W., et al. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland. Int J Radiat Oncol Biol Phys 52 (2002) 664-673
31. Lau W.K., Blute M.L., Bostwick D.G., et al. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: Differences in outcome between primary Gleason grades 3 and 4. J Urol 166 (2001) 1692-1697
32. Rohrmann S., Genkinger J.M., Burke A., et al. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology 69 (2007) 721-725
33. Park S.Y., Murphy S.P., Wilkens L.R., et al. Fat and meat intake and prostate cancer risk: The multiethnic cohort study. Int J Cancer 121 (2007) 1339-1345
34. Whittemore A.S., Kolonel L.N., Wu A.H., et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87 (1995) 652-661
35. Smith E.B., Frierson H.F., Mills S.E., et al. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: Is there evidence for systematic upgrading?. Cancer 94 (2002) 2282-2287